Comparison of baricitinib, upadacitinib, and tofacitinib mediated regulation of cytokine signaling in human leukocyte subpopulations
2019 · Arthritis Research & Therapy · 272 citations
https://doi.org/10.1186/s13075-019-1964-1
N
Nicole L Byers
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
9
Papers
806
Citations
7
h-index
7
i10-index
Nicole L Byers is an academic researcher from Eli Lilly (United States). The author has contributed to research in topics: Cytokine Signaling Pathways and Interactions & Rheumatoid Arthritis Research and Therapies & Systemic Lupus Erythematosus Research. The author has an h-index of 7, co-authored 8 publications.
Papers by this author
worksMechanism of baricitinib supports artificial intelligence‐predicted testing in <scp>COVID</scp> ‐19 patients
2020 · EMBO Molecular Medicine · 262 citations
https://doi.org/10.15252/emmm.202012697
Multicentre randomized controlled trial of structured transition on diabetes care management compared to standard diabetes care in adolescents and young adults with type 1 diabetes (Transition Trial)
2013 · BMC Pediatrics · 41 citations
https://doi.org/10.1186/1471-2431-13-163
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat